Czechia vs Northern Africa and Western Asia: Proportion of the target population who received the final dose of
Czechia
75.0%
in 2024
Northern Africa and Western Asia
2.0%
in 2024
Czechia rank
32nd
Northern Africa and Western Asia rank
35th
Proportion of the target population who received the final dose of over time
- Czechia
- Northern Africa and Western Asia
How they compare
Czechia currently reports 75.0% against 2.0% in Northern Africa and Western Asia, a difference of 73.0%.
That makes Czechia's figure about 37.5 times Northern Africa and Western Asia's.
Across all 11 years both countries report, Czechia has been ahead every year.
Czechia ranks 32nd and Northern Africa and Western Asia ranks 35th of 107 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 65.3% | 1.0% | 64.3% | Czechia |
| 2020s | 71.4% | 1.8% | 69.6% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Czechia or Northern Africa and Western Asia?
- Czechia, at 75.0% against 2.0% in Northern Africa and Western Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Czechia and Northern Africa and Western Asia?
- 73.0%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Northern Africa and Western Asia?
- 11 years are reported by both, from 2014 to 2024.
- How do Czechia and Northern Africa and Western Asia rank globally for proportion of the target population who received the final dose of?
- Czechia ranks 32nd and Northern Africa and Western Asia ranks 35th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.